CHI3L1 and myeloid sarcoma: A further marker for glial activation, especially microglial activation, chitinase-3-like protein 1 (CHI3L1), was shown to be elevated in the CSF of MS patients compared to controls and a putative prognostic biomarker in patients with a clinically isolated syndrome (CIS) (14–18).